SC 13G Filing

Company

Axsome Therapeutics, Inc.

Filed

April 27, 2017

Accession Number

0001105806-17-000010

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →